Pharmacology
Semaglutide pharmacokinetics: why once-weekly dosing works
A long half-life lets one weekly injection hold steady drug levels — here is the pharmacology in plain English.
Quick Answer
Semaglutide has an elimination half-life of about 7 days (one week), achieved by resisting DPP-4 breakdown and binding to albumin. That supports once-weekly subcutaneous injection; steady-state levels are reached after roughly 4–5 weeks. The oral form (Rybelsus) is taken daily on an empty stomach because its absorption is low and variable. Compounded semaglutide is not FDA-approved and may differ in formulation.
Key Facts
- Half-life: ~7 days (about one week)
- Injectable: once weekly; oral (Rybelsus): once daily
- Steady state: ~4–5 weeks at a given dose
- Long action comes from albumin binding + DPP-4 resistance
- Compounded products may differ in concentration/formulation — follow exact instructions
Engineered for a long half-life
Native GLP-1 lasts only minutes. Semaglutide is modified with a fatty-acid chain that binds albumin, the most abundant blood protein, and with changes that resist the DPP-4 enzyme. Together these extend its half-life to about a week, so weekly injections keep drug levels relatively stable rather than spiking and crashing.
Steady state and dose changes
Because each weekly dose is given before the previous one fully clears, levels accumulate until they plateau — steady state — after about four to five weeks. This is one reason dose increases are spaced roughly four weeks apart: the body needs time to reach and tolerate each new steady level (see why titration is slow).
Why the oral form is different
Oral semaglutide (Rybelsus) is taken daily, not weekly, because peptides are normally destroyed in the gut. It is formulated with an absorption enhancer and must be taken on an empty stomach with a small sip of water, waiting about 30 minutes before eating. Even then, absorption is low and variable — which is why oral and injectable doses are not interchangeable (see oral vs injectable).
Clearance and compounded caveats
Semaglutide is broken down into peptides and amino acids and cleared over weeks; after the last dose it takes roughly five weeks to largely leave the body. Branded pharmacokinetic data come from Novo Nordisk's products. Compounded semaglutide is not FDA-approved and can differ in concentration and form, so branded data should not be assumed to apply — follow the exact instructions for your specific preparation.
Frequently asked questions
How long does semaglutide stay in your system?
Its half-life is about a week, so it takes roughly 5 weeks (about five half-lives) to be largely cleared after the last dose.
Why is semaglutide injected only once a week?
Its long half-life keeps drug levels steady across the week, so one weekly injection is enough — unlike the oral form, which is taken daily.
References
- Overgaard RV, et al. Clinical pharmacokinetics of semaglutide. Clin Pharmacokinet. 2019.
- Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol. 2019;10:155.
- U.S. Food and Drug Administration. Wegovy, Ozempic and Rybelsus (semaglutide) prescribing information. Novo Nordisk.
Citations are for educational reference; this article summarizes published research in plain language and is not medical advice.
Bottom Line
Semaglutide's ~1-week half-life is what makes once-weekly injection possible, with steady levels after about a month. The daily oral form behaves differently. Compounded products can differ — follow the exact directions you are given.
Related from the Journal
Why titration is slow
Dose escalation explained.
Oral vs injectable
How Rybelsus differs from Wegovy/Ozempic.
Injection & storage
Practical handling basics.